EMAIL THIS PAGE TO A FRIEND

Oncotarget

Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.


PMID 26506422

Abstract

We're sorry this abstract is currently not available.